These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis. Lin AT; Clements PJ; Furst DE Rheum Dis Clin North Am; 2003 May; 29(2):409-26. PubMed ID: 12841302 [TBL] [Abstract][Full Text] [Related]
9. Treatment Considerations of Lung Involvement in Rheumatologic Disease. Robles-Perez A; Molina-Molina M Respiration; 2015; 90(4):265-74. PubMed ID: 26461464 [TBL] [Abstract][Full Text] [Related]
13. Clinical trials for the treatment of systemic sclerosis/scleroderma. Varga J; Ponor I Curr Rheumatol Rep; 1999 Oct; 1(1):13-4. PubMed ID: 11123008 [No Abstract] [Full Text] [Related]
14. Systemic sclerosis (scleroderma). Clinical management of its major complications. Legerton CW; Smith EA; Silver RM Rheum Dis Clin North Am; 1995 Feb; 21(1):203-16. PubMed ID: 7732169 [TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide therapy for scleroderma. Akesson A Curr Opin Rheumatol; 1998 Nov; 10(6):579-83. PubMed ID: 9812219 [TBL] [Abstract][Full Text] [Related]
16. Disease-modifying drugs for systemic sclerosis: why have we not found them yet? Derk CT Expert Rev Clin Immunol; 2011 Jul; 7(4):399-401. PubMed ID: 21790280 [No Abstract] [Full Text] [Related]
17. Determinants of pulmonary function improvement in patients with scleroderma and interstitial lung disease. Tzelepis GE; Plastiras SC; Karadimitrakis SP; Vlachoyiannopoulos PG Clin Exp Rheumatol; 2007; 25(5):734-9. PubMed ID: 18078622 [TBL] [Abstract][Full Text] [Related]
18. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. White B; Bauer EA; Goldsmith LA; Hochberg MC; Katz LM; Korn JH; Lachenbruch PA; LeRoy EC; Mitrane MP; Paulus HE Arthritis Rheum; 1995 Mar; 38(3):351-60. PubMed ID: 7880189 [TBL] [Abstract][Full Text] [Related]
19. Disease modification and other trials in systemic sclerosis have come a long way, but have to go further. Pope JE; Khanna D; Johnson SR; Clements P Arthritis Care Res (Hoboken); 2012 Jul; 64(7):955-9. PubMed ID: 22422634 [No Abstract] [Full Text] [Related]
20. Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosis. Holmberg LA; Furst DE; McSweeney PA; Nash RA J Rheumatol; 2009 Aug; 36(8):1839. PubMed ID: 19671826 [No Abstract] [Full Text] [Related] [Next] [New Search]